Table 1.
Correlation of clinicopathologic features with METTL3 expression in gastric cancer tissues.
| Numbera | METTL3 expression | P valueb | ||
|---|---|---|---|---|
| Clinicopathological features | Lowa | Higha | ||
| Gender | 0.6497 | |||
| Male | 68 (78.16%) | 29 (42.65%) | 39 (57.35%) | |
| Female | 19 (21.84%) | 7 (36.85%) | 12 (63.15%) | |
| Age | 0.8096 | |||
| ≥65 | 18 (20.69%) | 7 (38.89%) | 11 (61.11%) | |
| <65 | 69 (79.31%) | 29 (42.03%) | 40 (57.97%) | |
| Stage | 0.0056** | |||
| I + II | 29 (33.33%) | 18 (62.07%) | 11 (39.93%) | |
| III + IV | 58 (66.67%) | 18 (31.03%) | 40 (68.97%) | |
| Tumor invasion | 0.5317 | |||
| T1 or T2 or T3 | 30 (34.48%) | 12 (40.00%) | 18 (60.00%) | |
| T4 | 57 (65.52%) | 24 (42.11%) | 33 (57.89%) | |
| Lymph node involvement | 0.0251* | |||
| Yes | 62 (71.26%) | 21 (33.87%) | 41 (66.13%) | |
| No | 25 (28.74%) | 15 (60.00%) | 10 (40.00%) | |
| Metastasis | 0.0639 | |||
| M0 | 68 (78.16%) | 32 (47.06%) | 36 (52.94%) | |
| M1 | 19 (21.84%) | 4 (21.05%) | 15 (78.95%) | |
| Differentiation | 0.2849 | |||
| Poorly | 47 (54.02%) | 17 (36.17%) | 30 (63.83%) | |
| Well | 40 (45.98%) | 19 (47.50%) | 21 (52.50%) | |
| Microvascular invasion | 0.0346* | |||
| Present | 16 (28.07%) | 4 (25.00%) | 12 (75.00%) | |
| Absent | 41 (71.93%) | 23 (56.10%) | 18 (43.90%) | |
aData are presented as numbers (proportions).
bP values were calculated by Chi-square test or Fisher’s exact test.
*P < 0.05; **P < 0.01.